Monitoring legislative and regulatory activities impacting the pharmaceutical industry Issue related to Purdue Pharma inc.
2025 · 3rd Quarter (July 1 - Sep 30)
KNOA PHARMA, FORMERLY REPORTED AS, PURDUE PHARMA L.P.
Filed by BROWNSTEIN HYATT FARBER SCHRECK, LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Nov 6, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Filing UUID
- ee0c6e77-7237-4088-b2c5-a3339beab509
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.